BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19443159)

  • 1. DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
    Farace P; Merigo F; Fiorini S; Nicolato E; Tambalo S; Daducci A; Degrassi A; Sbarbati A; Rubello D; Marzola P
    Eur J Radiol; 2011 Apr; 78(1):52-9. PubMed ID: 19443159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer: comparison of dynamic contrast-enhanced MRI techniques for localization of peripheral zone tumor.
    Rosenkrantz AB; Sabach A; Babb JS; Matza BW; Taneja SS; Deng FM
    AJR Am J Roentgenol; 2013 Sep; 201(3):W471-8. PubMed ID: 23971479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Washout of small molecular contrast agent in carcinoma-derived experimental tumors.
    Galiè M; Farace P; Merigo F; Fiorini S; Tambalo S; Nicolato E; Sbarbati A; Marzola P
    Microvasc Res; 2009 Dec; 78(3):370-8. PubMed ID: 19804787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA.
    Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K
    J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
    Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
    Øvrebø KM; Ellingsen C; Hompland T; Rofstad EK
    Acta Oncol; 2013 Apr; 52(3):604-11. PubMed ID: 22671573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
    Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
    Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
    Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
    Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI.
    Noworolski SM; Henry RG; Vigneron DB; Kurhanewicz J
    Magn Reson Med; 2005 Feb; 53(2):249-55. PubMed ID: 15678552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB; Loddenkemper C; Huppertz A; Valdeig S; Stroux A; Seja M; Wolf KJ; Albrecht T
    AJR Am J Roentgenol; 2009 Oct; 193(4):1053-60. PubMed ID: 19770329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.